Stone X Group Inc. Adicet Bio, Inc. Transaction History
Stone X Group Inc.
- $1.58 Billion
- Q1 2025
A detailed history of Stone X Group Inc. transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Stone X Group Inc. holds 12,448 shares of ACET stock, worth $8,962. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,448Holding current value
$8,962% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACET
# of Institutions
63Shares Held
57.5MCall Options Held
36.9KPut Options Held
16.5K-
Orbimed Advisors LLC San Diego, CA11.4MShares$8.24 Million0.27% of portfolio
-
Tang Capital Management LLC San Diego, CA8.22MShares$5.92 Million0.41% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.54MShares$5.43 Million0.12% of portfolio
-
Goldman Sachs Group Inc New York, NY3.82MShares$2.75 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$2.31 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $28.8M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...